Efficacy/effectiveness Coverage Administration Modeling All age groups Mumps Measles Rubella
Efficacy/effectiveness All age groups Measles Mumps Rubella COVID-19
Vaccine/vaccination All age groups COVID-19 Measles Mumps Rubella
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
Coverage Newborn (0-1 years) Children (2-9 years) Mumps Diphtheria Tetanus Pertussis Measles Rubella Poliomyelitis
Agenda & Minutes Argentina Measles
Download:
Agenda & Minutes Argentina Measles Poliomyelitis Meningococcal disease Yellow fever
Download:
Agenda & Minutes United States of America Human papillomavirus (HPV) Pneumococcal disease Measles Herpes zoster Pertussis Influenza Hepatitis A Meningococcal disease Dengue
Download:
anthrax supply shortage Agenda & Minutes United States of America Japanese encephalitis Influenza Human papillomavirus (HPV) Pneumococcal disease Meningococcal disease Herpes zoster Hepatitis A
Download:
immunodeficiency Agenda & Minutes Germany Measles Mumps Rubella Pertussis Varicella
Download: